PAR PHARMACEUTICAL COMPANIES, INC. Operating Expenses
PAR PHARMACEUTICAL COMPANIES, INC. reported Operating Expenses of $93.89 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for the quarter ending 2015-06-30 was $93.89M, a 15.44% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for the quarter ending 2015-03-31 was $83.57M, a 34.95% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for the quarter ending 2014-09-30 was $170.66M, a 60.82% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for the quarter ending 2014-06-30 was $111.04M, a 67.23% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for fiscal 2011 was $437.46M, a 77.37% increase from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for fiscal 2010 was $246.63M, a 19.91% increase from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. operating expenses for fiscal 2009 was $205.68M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2015-06-30 | $93.89M 10-Q · filed 2015-08-06 | $177.46M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | $83.57M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | $170.66M 10-Q · filed 2014-11-12 | $281.69M derived: sum of 2 quarters · filed 2015-08-06 | $410.17M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $111.04M 10-Q · filed 2015-08-06 | $239.51M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $128.47M 10-Q · filed 2015-05-11 | |||
| 2013-09-30 | $106.12M 10-Q · filed 2014-11-12 | $172.51M derived: sum of 2 quarters · filed 2014-11-12 | $235.35M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $66.40M 10-Q · filed 2014-08-11 | $129.23M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $62.84M 10-Q · filed 2014-05-15 | |||
| 2012-06-30 | $60.38M 10-Q · filed 2012-08-02 | $179.44M 10-Q · filed 2012-08-02 | $242.10M derived: sum of 3 quarters · filed 2012-08-02 | $287.47M derived: sum of 4 quarters · filed 2012-08-02 |
| 2012-03-31 | $119.06M 10-Q · filed 2012-05-08 | $181.72M derived: sum of 2 quarters · filed 2012-05-08 | $227.09M derived: sum of 3 quarters · filed 2012-05-08 | $308.31M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-12-31 | $62.66M 10-K · filed 2012-02-28 | $108.03M derived: sum of 2 quarters · filed 2012-02-28 | $189.25M derived: sum of 3 quarters · filed 2012-08-02 | $437.46M 10-K · filed 2012-02-28 |
| 2011-09-30 | $45.37M 10-K · filed 2012-02-28 | $126.59M derived: sum of 2 quarters · filed 2012-08-02 | $374.81M 10-Q · filed 2011-11-02 | $445.28M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-06-30 | $81.22M 10-Q · filed 2012-08-02 | $329.43M 10-Q · filed 2012-08-02 | $399.90M derived: sum of 3 quarters · filed 2012-08-02 | $462.66M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-03-31 | $248.22M 10-Q · filed 2012-05-08 | $318.69M derived: sum of 2 quarters · filed 2012-05-08 | $381.44M derived: sum of 3 quarters · filed 2012-05-08 | $448.90M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $70.47M 10-K · filed 2012-02-28 | $133.23M derived: sum of 2 quarters · filed 2012-02-28 | $200.69M derived: sum of 3 quarters · filed 2012-02-28 | $246.63M 10-K · filed 2012-02-28 |
| 2010-09-30 | $62.76M 10-K · filed 2012-02-28 | $130.22M derived: sum of 2 quarters · filed 2012-02-28 | $176.16M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $67.46M 10-K · filed 2012-02-28 | $113.41M 10-Q · filed 2011-08-03 | ||
| 2010-03-31 | $45.95M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $205.68M 10-K · filed 2012-02-28 |